跳至主要内容
临床试验/ACTRN12616000306415
ACTRN12616000306415已完成未知

Safety and Feasibility Study of the Tempo (Trademark) Temporary Pacing Lead in patients undergoing a transcatheter cardiac procedure requiring temporary intracardiac pacing in New Zealand

BioTrace Medical Inc.0 个研究点目标入组 25 人开始时间: 2016年3月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Subject requires temporary intracardiac pacing.
  • Subject is a surgical candidate and able to tolerate general anesthesia.
  • Subject scheduled to undergo TAVR, BAV or an EP procedure.

排除标准

  • Subject has a prosthetic tricuspid valve.
  • Subject has a history of known coagulopathy and/or thrombocytopenia (platelets <100).
  • Immediately prior to the procedure, there is presence of greater than mild pericardial effusion.
  • Subject has a history of major bleeding within previous 6 months of the planned procedure, or an absolute contraindication to anticoagulation therapy.
  • For EP Subjects Only: Subject may not be 75 years of age or older at the time of consent (inclusive).

研究者

发起方
BioTrace Medical Inc.

相似试验